The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

The Department of Health and Human Services moved to eliminate thimerosal from flu shots in a victory for antivaccine ...

Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GSK PLC GSK shares rose 1.78% to £13.72 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% to 9,061.49. GSK PLC ...

GSK said the U.S. Food and Drug Administration extended its review period for Blenrep combinations to treat patients with relapsed or refractory multiple myeloma.

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a ...

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without ...

Early Anthropic hire raises $15M for AIUC to insure AI agents, helping enterprises deploy artificial intelligence securely with risk coverage and safety standards.

Today, as European stocks benefit more from the optimism that the US-Japan deal will create for the trade outlook, the FTSE ...

Bengaluru: Syngene International has announced the appointment of Chethan Yogesh as the Company Secretary and Compliance ...